Intervention

LY3437943

ClinicalTrials.gov intervention label

Clinical trials8
Recruiting0
Common conditions4
Lead sponsors shown1

Clinical trials

8 shown
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943NCT06313528 · 2024-03-20
COMPLETED
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or ObeseNCT06039826 · 2023-09-12
COMPLETED
A Study of LY3437943 in Chinese Participants With Obesity Or OverweightNCT05548231 · 2022-10-24
COMPLETED
A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese ParticipantsNCT05445232 · 2022-07-08
COMPLETED
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)NCT04823208 · 2021-05-24
COMPLETED
A Study of LY3437943 in Participants Who Have Obesity or Are OverweightNCT04881760 · 2021-05-20
COMPLETED
A Study of LY3437943 in Participants With Type 2 DiabetesNCT04867785 · 2021-05-13
COMPLETED
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)NCT04143802 · 2019-12-18
COMPLETED

Trial status mix

COMPLETED8

Phase mix

PHASE16
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.